AzTrials
AzTrials

Respiratory FailureDYSPONCT04582838

Photoplethysmographic Scaling of Dyspnoea

An observational study of Respiratory Failure, run by Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu at 2 sites in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Timely prediction of impending respiratory failure is vital, yet relies on subjective clinical assessment of the patient's respiratory status. Pulse oximetry plethysmographic signal analysis is indicative of the effort to breathe and may provide an objective measurement of respiratory loading. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Respiratory Failure
What is being tested?
Pulse oximeter and ECG
How many people
60 participants
Where
2 sitesRomania
Study dates
1 Oct 2020to 30 Jul 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Spontaneously breathing ICU (COVID and non-COVID-19) adult patients with sinus rhythm, under any form of non-invasive respiratory support.

Who may be able to join

  • Informed consent from patient or next-of-kin according to local administrative decision
  • Spontaneous breathing, including during prone position
  • Sinus rhythm
  • Minimum standards for ICU monitoring: ECG, blood pressure (invasive or non-invasive), respiratory rate (by ECG signal), SpO2 and temperature

Who cannot join

  • Suspected pregnancy
  • Weight > 120 Kg or < 60 kg
  • Emergency or urgency
  • Intubated ( and mechanically ventilated) patient
  • Non- sinus rhythm
  • Left ventricular ejection fraction (LVEF) ≤ 30%
  • Right ventricular (RV) dysfunction ( RVEF ≤ 30% at transthoracic echocardiography (TTE))
  • Significant pulmonary hypertension (PHT) (TTE: mean pulmonary arterial pressure (mPAP) ≥ 35 mm.Hg)

Trial locations and contacts

2 sites in 1 country.

Romania2 sites
  • Clinical Emergency Hospital Bucharest

    Bucharest, 014461

  • Clinical Hospital of Infectious and Tropical Diseases "Dr. Victor Babes"

    Bucharest, 030303

Other trials in Romania

About this study

Official title: Photoplethysmographic Signal Analysis as a Proxy for Excessive Effort and Impending Respiratory Failure

Timely prediction of impending respiratory failure is vital, yet relies on subjective clinical assessment of the patient's respiratory status. Pulse oximetry plethysmographic signal analysis is indicative of the effort to breathe and may provide an objective measurement of respiratory loading.

Read the detailed description

Initiating invasive mechanical ventilation is a vital and delay-critical decision. Precise and timely prediction of impending respiratory failure would be highly consequential. Subjective evaluation of respiratory loading conditions is inconsistent, imprecise and may result in erroneous management. Photoplethysmographic (POP) waveform analysis provides a non-invasive, readily available tool to estimate breathing effort in a semiquantitative fashion.

It is the aim of this study to examine:

  1. if the degree of dyspnoea, when clinically assessed by means of the respiratory rate and SpO2 values, correlates with the SpO2 wave variations (ΔPOP) in ICU spontaneously breathing COVID-19 and non-COVID-19 patients.
  2. if a ΔPOP threshold could be identified to adequately predict further need of orotracheal intubation and invasive mechanical ventilation.

This study consists of three main steps:

  1. Clinical evaluation of dyspnoea based on: 1.1. Respiratory rate 1.2. Oxygen saturation (SpO2)
  2. Storage of SpO2 curve for ΔPOP computation according to a proprietary algorithm after offline POP analysis .
  3. Within a time frame of 10 days from when the first two steps are met, monitor for need of invasive ventilatory support.
Being tested
Pulse oximeter, ECG
Keywords
breathing, effort, plethysmography, pulse oximetry, dyspnoea, mechanical ventilation
Medical subject headings
Respiratory Insufficiency, Respiratory Aspiration, Dyspnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulse oximeterDiagnostic test

    In both groups, pulse oximeters provide continuous monitoring of oxygen saturation (SpO2).

    Also, SpO2 curve can be recorded for off-line analysis.

  • ECGDiagnostic test

    ECG signal is used to monitor respiratory rate (RR).

Study groups in NCT04582838
Study groupRoleWhat they receive
Spontaneous breathing ICU non-COVIDSpontaneously breathing non-COVID-19 critically ill patients with sinus rhythm. Inclusion and exclusion criterion are listed elsewhere.
Receives: Diagnostic Test: Pulse oximeter; Diagnostic Test: ECG
Spontaneous breathing ICU COVIDSpontaneously breathing COVID-19 critically ill patients with sinus rhythm. Inclusion and exclusion criterion are listed elsewhere.
Receives: Diagnostic Test: Pulse oximeter; Diagnostic Test: ECG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of failure of spontaneous breathing

    Number of patients who fail spontaneous breathing (SB). Failure of SB is defined as death or need of invasive mechanical ventilation whereas SB includes any form of non-invasive ventilatory support

    Measured: Day 10

Secondary outcomes (3)
  1. Respiratory rate

    Patient's respiratory rate during non-invasive respiratory support as derived from an ECG signal

    Measured: Day 0

  2. SpO2 under non-invasive respiratory support

    Peripheral oxygen saturation (SpO2) as measured with a pulse oximeter during any form of non-invasive ventilatory support

    Measured: Day 0

  3. ΔPOP

    Photoplethysmographic variation index following offline computation of the SpO2 curve stored at day 0 according to a proprietary algorithm

    Measured: day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2020
  2. Study start1 Oct 2020
  3. Primary completion30 May 2021
  4. Study completion30 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04582838
Sponsor's protocol ID
18751
Other IDs
Dyspnoea - SpO2 curve study
Acronym
DYSPO
Status last verified
Aug 2021
First submitted
4 Oct 2020
Last updated
3 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Addison PS. Respiratory effort from the photoplethysmogram. Med Eng Phys. 2017 Mar;41:9-18. doi: 10.1016/j.medengphy.2016.12.010. Epub 2017 Jan 23.

    PubMed 28126420
  • Perel A. Excessive variations in the plethysmographic waveform during spontaneous ventilation: an important sign of upper airway obstruction. Anesth Analg. 2014 Dec;119(6):1288-92. doi: 10.1213/ANE.0000000000000378.

    PubMed 25405690
  • Khandoker AH, Karmakar CK, Penzel T, Glos M, Schoebel C, Palaniswami M. Estimating relative respiratory effort from features of Photo-Plethysmography signal. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:6575-8. doi: 10.1109/EMBC.2013.6611062.

    PubMed 24111249
  • Addison PS. Respiratory modulations in the photoplethysmogram (DPOP) as a measure of respiratory effort. J Clin Monit Comput. 2016 Oct;30(5):595-602. doi: 10.1007/s10877-015-9763-y. Epub 2015 Sep 16.

    PubMed 26377021

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Failure, run by Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu at 2 sites in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of failure of spontaneous breathing (time frame: Day 10). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04582838, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in